O
XRAY icon

OrbiMed’s Dentsply Sirona XRAY Stock Holding History

OrbiMed’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,889,200
Closed -$71.3M – 153
2018
Q3 		$71.3M Sell
1,889,200
-504,300
-21% -$21M 0.86% 36
2018
Q2 		$105M Buy
2,393,500
+2,168,500
+964% +$102M 1.25% 27
2018
Q1 		$11.3M Buy
+225,000
New +$13.2M 0.14% 102

Other funds holding XRAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

OrbiMed's XRAY Position: Q4 2018 in Review

OrbiMed sold out of Dentsply Sirona (XRAY) in Q4 2018, closing a stake of 1,889,200 shares — an estimated $71.3M sold.

OrbiMed first reported a position in XRAY in Q1 2018 and held it in 3 quarters. The position peaked at $105M in Q2 2018. 494 funds tracked by Wall St. Rank hold XRAY as of Q4 2018.

  • OrbiMed reported no remaining Dentsply Sirona position as of Q4 2018 after selling out during the quarter.
  • OrbiMed sold 1,889,200 Dentsply Sirona shares in Q4 2018, an estimated $71.3M.
  • OrbiMed first reported a position in Dentsply Sirona in Q1 2018 and held it in 3 quarters.
  • OrbiMed's Dentsply Sirona position peaked at $105M in Q2 2018.
  • 494 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2018.

Based on OrbiMed's 13F filing for Q4 2018, filed 14 Feb 2019.